Literature DB >> 2536746

Microthrombomodulin. Residues 310-486 from the epidermal growth factor precursor homology domain of thrombomodulin will accelerate protein C activation.

D J Stearns1, S Kurosawa, C T Esmon.   

Abstract

Thrombomodulin is the endothelial cell cofactor for thrombin-catalyzed activation of protein C. Recently, we isolated a 10-kDa thrombin binding fragment, CB3, from the epidermal growth factor precursor homology domain (epidermal growth factor (EGF)-like regions) of thrombomodulin (Kurasawa, S., Stearns, D. J., Jackson, K.W., and Esmon, C.T. (1988) J. Biol. Chem. 263, 5993-5996). The CB3 fragment did not, however, support protein C activation. A 29-kDa fragment, called CB23, has now been isolated and corresponds to residues 310-486 in the EGF-like region of thrombomodulin. The CB23 fragment bound thrombin and accelerated thrombin-catalyzed protein C activation. With two separate preparations of CB23, the Km for protein C was 1.6 and 1.9 microM and the Kd for thrombin was 8.9 and 13.2 nM. The carboxyl terminus of CB23 and CB3 was identified by isolation and sequence analysis of a tryptic peptide from CB3. The sequence of this peptide corresponded to Asn457-Ser486, indicating that the carboxyl terminus of these fragments is 6 residues beyond the sixth EGF-like region of thrombomodulin. In addition, although CB3 cannot accelerate protein C activation, CB3 did inhibit the rate of thrombin-catalyzed fibrinopeptide release from fibrinogen. Thus, like native thrombomodulin, CB3 will alter thrombin's substrate specificity, but protein C activation requires additional information all of which can be provided by other regions of the EGF-like domain.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2536746

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  23 in total

1.  A novel endothelial cell surface receptor tyrosine kinase with extracellular epidermal growth factor homology domains.

Authors:  J Partanen; E Armstrong; T P Mäkelä; J Korhonen; M Sandberg; R Renkonen; S Knuutila; K Huebner; K Alitalo
Journal:  Mol Cell Biol       Date:  1992-04       Impact factor: 4.272

2.  Mutations in the fourth EGF-like domain affect thrombomodulin-induced changes in the active site of thrombin.

Authors:  Julia R Koeppe; Muneera A Beach; Abel Baerga-Ortiz; S Jordan Kerns; Elizabeth A Komives
Journal:  Biochemistry       Date:  2008-09-20       Impact factor: 3.162

3.  The fifth epidermal growth factor-like domain of thrombomodulin does not have an epidermal growth factor-like disulfide bonding pattern.

Authors:  C E White; M J Hunter; D P Meininger; S Garrod; E A Komives
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-17       Impact factor: 11.205

4.  Inhibition of thrombomodulin surface expression and protein C activation by the thrombogenic agent homocysteine.

Authors:  S R Lentz; J E Sadler
Journal:  J Clin Invest       Date:  1991-12       Impact factor: 14.808

Review 5.  Glycosaminoglycans and the regulation of blood coagulation.

Authors:  M C Bourin; U Lindahl
Journal:  Biochem J       Date:  1993-01-15       Impact factor: 3.857

Review 6.  Pathogenesis of disseminated intravascular coagulation in patients with acute promyelocytic leukemia, and its treatment using recombinant human soluble thrombomodulin.

Authors:  Takayuki Ikezoe
Journal:  Int J Hematol       Date:  2013-11-12       Impact factor: 2.490

7.  Thrombin inhibition by cyclic peptides from thrombomodulin.

Authors:  J C Lougheed; C L Bowman; D P Meininger; E A Komives
Journal:  Protein Sci       Date:  1995-04       Impact factor: 6.725

8.  Synthesis, activity, and preliminary structure of the fourth EGF-like domain of thrombomodulin.

Authors:  D P Meininger; M J Hunter; E A Komives
Journal:  Protein Sci       Date:  1995-09       Impact factor: 6.725

9.  Mutagenesis studies toward understanding allostery in thrombin.

Authors:  Shabir H Qureshi; Likui Yang; Chandrashekhara Manithody; Alexei V Iakhiaev; Alireza R Rezaie
Journal:  Biochemistry       Date:  2009-09-01       Impact factor: 3.162

10.  Thrombin-binding affinities of different disulfide-bonded isomers of the fifth EGF-like domain of thrombomodulin.

Authors:  M J Hunter; E A Komives
Journal:  Protein Sci       Date:  1995-10       Impact factor: 6.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.